CS logo
small CS logo
MAX Balaji Hospital

Delhi, India
General hospital in Delhi
108A, IP Ext, I.P.Extension, Patparganj, Delhi, 110092

About MAX Balaji Hospital


"Max Super Speciality Hospital, Patparganj is a 400+ bedded highly advanced healthcare facility offering services across all major medical disciplines including Oncology, Cardiology, Obstetrics, Gynaecology, Orthopaedics, Urology, Neurology, Minimal Access, Metabolic, Bariatric Surgery, and Kidney Transplants. Max Super Speciality Hospital, Patparganj is a unit of Balaji Medical and Diagnostic Research Centre where experts have performed more than 30,000 operations including all advanced and basic surgeries. Being one of the best hospitals in Delhi, it is equipped with the necessary infrastructure that is required to carry out such advanced surgeries. Emergency services are available 24*7 with a Blood Bank, ATM, and other amenities"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at MAX Balaji Hospital


During the past decade, MAX Balaji Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at MAX Balaji Hospital


According to Clinical.Site data, the most researched conditions in "MAX Balaji Hospital" are "Breast Cancer" (2 trials), "Anemia" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "MAX Balaji Hospital" in a lesser frequency.

Clinical Trials Intervention Types at MAX Balaji Hospital


Most popular intervention types in "MAX Balaji Hospital" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "Trastuzumab" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials) and "Atezolizumab Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at MAX Balaji Hospital


The vast majority of trials in "MAX Balaji Hospital" are 3 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at MAX Balaji Hospital


Currently, there are NaN active trials in "MAX Balaji Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in MAX Balaji Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MAX Balaji Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".